iifl-logo

Ankur Drugs & Pharma Ltd Profit & Loss Statement

3.65
(-3.95%)
Sep 10, 2013|12:00:00 AM

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

FINANCIALS

Y/e 31 Mar( In .Cr)Mar-2012Mar-2011

Revenue

151.48

824.84

yoy growth (%)

-81.63

Raw materials

-113.18

-616.41

As % of sales

74.71

74.73

Employee costs

-18.8

-20.44

As % of sales

12.41

2.47

Other costs

-47.4

-54.09

As % of sales (Other Cost)

31.28

6.55

Operating profit

-27.9

133.89

OPM

-18.42

16.23

Depreciation

-66.03

-60.79

Interest expense

-58.35

-120.79

Other income

0.18

0.93

Profit before tax

-152.1

-46.76

Taxes

-19.02

-22.04

Tax rate

12.5

47.13

Minorities and other

0

0

Adj. profit

-171.12

-68.8

Exceptional items

-136.36

0

Net profit

-307.49

-68.8

yoy growth (%)

346.88

NPM

-202.97

-8.34

Ankur Drugs & Pharma Ltd : related Articles

No Record Found

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2025, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Securities Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)

ISO certification icon
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.